For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...
Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, ...
The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.
Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...
BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...
The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.
RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...
After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...
A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.
AlloCell has been used in ten prior cell therapy clinical trials and with the addition of the ACHIEVE trial is being actively used in four clinical trials. The ACHIEVE clinical trial is an adaptive, ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
What is it like to be in a clinical trial? It requires dedication, but it can be immensely rewarding — and not just for you.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback